SBH Sciences

Executive Summary

SBH Sciences is a US-based contract research organization (CRO) and biotechnology product company founded in 1996 and headquartered in Natick, Massachusetts. The company provides integrated services for drug discovery and development, specializing in cell-based assays, biomarker testing, and the manufacturing of recombinant cytokines and antibodies. Serving as a scientific ecosystem, SBH supports biotech startups and established companies from early research through IND-enabling studies. Its dual revenue model—offering both fee-for-service CRO work and proprietary biological products—provides diversification and a steady cash flow, allowing the company to invest in technology and capacity expansion without relying on venture capital.

Upcoming Catalysts (preview)

• Q3 2026Launch of new cell therapy assay platform65% success
• Q4 2026Strategic partnership with a major pharma for biomarker testing50% success
• Q2 2026Expansion of recombinant protein catalog with novel cytokine targets75% success